NCT00121238View on ClinicalTrials.gov

Cilengitide in Treating Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2015

Conditions
Recurrent Prostate CancerStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate CancerStage III Prostate Cancer
Interventions
DRUG

cilengitide

Given IV

Trial Locations (1)

48109

University of Michigan University Hospital, Ann Arbor

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00121238 - Cilengitide in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter